Skip to content

Neurodevelopmental outcome and quality of life in infants with (congenital) liver disease

Congenital Liver diseases and Neurological Outcome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27464
Enrollment
75
Registered
2016-10-25
Start date
2016-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental outcome Congenital liver disease Biliary Atresie Liver transplantation Behavioural problems Quality of life Neurologische uitkomst Ontwikkelingsproblemen Kwaliteit van leven Aangeboren leveraandoeningen Galgangatresie

Interventions

None listed

Sponsors

-
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - All infants with congenital liver disease in the Netherlands. - All infants who had a liver transplantation < 5 year in the Netherlands.

Exclusion criteria

Exclusion criteria: - Deceased infants. -Neurodevelopmental sequelae due to other problems (e.g. syndromal)

Design outcomes

Primary

MeasureTime frame
Neurodevelopmenatal outcome Quality of Life

Secondary

MeasureTime frame
Risk factors for impaired neurodevelopmental outcome / Quality of life

Contacts

Public ContactJ.L.M. Bruggink

Department of Pediatric Surgery - University Medical Center Groningen

j.l.m.bruggink@umcg.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)